Hereditary alpha tryptasemia (HAT) Hereditary alpha tryptasemia (HAT) is a rare genetic condition that is caused by mutations in the TPSAB1 gene, which codes for alpha tryptase, a type of enzyme that is released from mast cells. Mast cells are a type of white blood...
The first patient in the VITESSE clinical trial was screened in Normal, Illinois, by the research team led by Principal Investigator Dr. Dareen Siri MD FAAAAI, FACAAI. Dr. Siri is among the Principle Investigators leading clinical trials across United States, Canada,...
